| Name | Family Vision Center |
|---|---|
| Organization Name | Benjamin T Hubbard Jr |
| Location | 260 Power Dr, Batesville, Mississippi 38606 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (662) 563-5533 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Finding ways to counteract or disrupt the invasive nature of cancer cells, called "metastasis," has been a long-term goal of cancer researchers. Now, researchers at Moffitt Cancer Center in Tampa, Fla., have identified an interactive pathway that regulates metastases in some cancers that may be vulnerable to chemical targeting in order to prevent cancer cell proliferation and tumor growth.
According to a study led by Ludwig-Maximilians-Universitaet in Munich researchers, a majority of patients diagnosed with breast cancer go on to develop symptoms of post-traumatic stress disorder, and in most of these cases the symptoms persist for at least a year.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
A new study describes a predictive model of protective immunity against SARS-CoV-2 infection that could help evolve optimal vaccination strategies to maintain protection and reduce the death rate.
The U.S. Food and Drug Administration has approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).
› Verified 8 days ago
| NPI Number | 1275792046 |
| Organization Name | BENJAMIN T HUBBARD JR |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 260 Power Dr, Batesville, MS 38606 |
| Phone Number | 662-563-5533 |
News Archive
Finding ways to counteract or disrupt the invasive nature of cancer cells, called "metastasis," has been a long-term goal of cancer researchers. Now, researchers at Moffitt Cancer Center in Tampa, Fla., have identified an interactive pathway that regulates metastases in some cancers that may be vulnerable to chemical targeting in order to prevent cancer cell proliferation and tumor growth.
According to a study led by Ludwig-Maximilians-Universitaet in Munich researchers, a majority of patients diagnosed with breast cancer go on to develop symptoms of post-traumatic stress disorder, and in most of these cases the symptoms persist for at least a year.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
A new study describes a predictive model of protective immunity against SARS-CoV-2 infection that could help evolve optimal vaccination strategies to maintain protection and reduce the death rate.
The U.S. Food and Drug Administration has approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).
› Verified 8 days ago
News Archive
Finding ways to counteract or disrupt the invasive nature of cancer cells, called "metastasis," has been a long-term goal of cancer researchers. Now, researchers at Moffitt Cancer Center in Tampa, Fla., have identified an interactive pathway that regulates metastases in some cancers that may be vulnerable to chemical targeting in order to prevent cancer cell proliferation and tumor growth.
According to a study led by Ludwig-Maximilians-Universitaet in Munich researchers, a majority of patients diagnosed with breast cancer go on to develop symptoms of post-traumatic stress disorder, and in most of these cases the symptoms persist for at least a year.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
A new study describes a predictive model of protective immunity against SARS-CoV-2 infection that could help evolve optimal vaccination strategies to maintain protection and reduce the death rate.
The U.S. Food and Drug Administration has approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).
› Verified 8 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 985 Eureka Rd, Batesville, Mississippi 38606 Phone: (662) 563-7095 | |
Kroger Pharmacy #434 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 110 Keating Rd, Batesville, Mississippi 38606 Phone: (662) 578-9917 | |
Walmart Pharmacy 10-1468 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 205 House Carlson Dr, Batesville, Mississippi 38606 Phone: (662) 563-3141 | |
Walgreens #11289 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 105 Highway 51 N, Batesville, Mississippi 38606 Phone: (662) 563-2855 | |
Dura Med Type: DME Supplier - Oxygen Equipment & Supplies Location: 443 Highway 6 E, Batesville, Mississippi 38606 Phone: (662) 561-0261 |